X-54810072-A-G
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_177433.3(MAGED2):āc.396A>Gā(p.Thr132=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.373 in 1,203,510 control chromosomes in the GnomAD database, including 60,298 homozygotes. There are 145,279 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Genomes: š 0.45 ( 8802 hom., 13642 hem., cov: 21)
Exomes š: 0.37 ( 51496 hom. 131637 hem. )
Consequence
MAGED2
NM_177433.3 synonymous
NM_177433.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -4.75
Genes affected
MAGED2 (HGNC:16353): (MAGE family member D2) This gene is a member of the MAGED gene family. The MAGED genes are clustered on chromosome Xp11. This gene is located in Xp11.2, a hot spot for X-linked intellectual disability (XLID). Mutations in this gene cause a form of transient antenatal Bartter's syndrome. This gene may also be involved in several types of cancer, including breast cancer and melanoma. The protein encoded by this gene is progressively recruited from the cytoplasm to the nucleoplasm during the interphase and after nucleolar stress and is thus thought to play a role in cell cycle regulation. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2017]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-1.01).
BP6
Variant X-54810072-A-G is Benign according to our data. Variant chrX-54810072-A-G is described in ClinVar as [Benign]. Clinvar id is 1258035.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-54810072-A-G is described in Lovd as [Likely_benign].
BP7
Synonymous conserved (PhyloP=-4.75 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.661 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MAGED2 | NM_177433.3 | c.396A>G | p.Thr132= | synonymous_variant | 3/13 | ENST00000375068.6 | NP_803182.1 | |
MAGED2 | NM_014599.6 | c.396A>G | p.Thr132= | synonymous_variant | 3/13 | NP_055414.2 | ||
MAGED2 | NM_201222.3 | c.396A>G | p.Thr132= | synonymous_variant | 3/13 | NP_957516.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MAGED2 | ENST00000375068.6 | c.396A>G | p.Thr132= | synonymous_variant | 3/13 | 1 | NM_177433.3 | ENSP00000364209 | P1 |
Frequencies
GnomAD3 genomes AF: 0.446 AC: 48518AN: 108902Hom.: 8808 Cov.: 21 AF XY: 0.435 AC XY: 13592AN XY: 31246
GnomAD3 genomes
AF:
AC:
48518
AN:
108902
Hom.:
Cov.:
21
AF XY:
AC XY:
13592
AN XY:
31246
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.400 AC: 69792AN: 174666Hom.: 10295 AF XY: 0.383 AC XY: 23198AN XY: 60506
GnomAD3 exomes
AF:
AC:
69792
AN:
174666
Hom.:
AF XY:
AC XY:
23198
AN XY:
60506
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.366 AC: 400152AN: 1094553Hom.: 51496 Cov.: 33 AF XY: 0.365 AC XY: 131637AN XY: 360431
GnomAD4 exome
AF:
AC:
400152
AN:
1094553
Hom.:
Cov.:
33
AF XY:
AC XY:
131637
AN XY:
360431
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.446 AC: 48552AN: 108957Hom.: 8802 Cov.: 21 AF XY: 0.436 AC XY: 13642AN XY: 31311
GnomAD4 genome
AF:
AC:
48552
AN:
108957
Hom.:
Cov.:
21
AF XY:
AC XY:
13642
AN XY:
31311
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Nov 08, 2018 | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Bartter disease type 5 Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Sep 05, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at